UBS Group’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28.2M Buy
1,272,499
+782,226
+160% +$17.4M ﹤0.01% 1602
2025
Q1
$9.11M Buy
490,273
+453,667
+1,239% +$8.43M ﹤0.01% 2439
2024
Q4
$485K Sell
36,606
-32
-0.1% -$424 ﹤0.01% 4718
2024
Q3
$1.23M Buy
36,638
+2,060
+6% +$69K ﹤0.01% 3427
2024
Q2
$867K Sell
34,578
-29,588
-46% -$741K ﹤0.01% 3508
2024
Q1
$1.45M Buy
64,166
+45,424
+242% +$1.02M ﹤0.01% 3256
2023
Q4
$401K Buy
18,742
+1,156
+7% +$24.8K ﹤0.01% 4130
2023
Q3
$316K Sell
17,586
-17,611
-50% -$316K ﹤0.01% 3932
2023
Q2
$716K Buy
35,197
+31,693
+904% +$645K ﹤0.01% 3550
2023
Q1
$76.2K Sell
3,504
-48,287
-93% -$1.05M ﹤0.01% 5061
2022
Q4
$1.61M Buy
51,791
+41,097
+384% +$1.27M ﹤0.01% 2739
2022
Q3
$273K Sell
10,694
-11,431
-52% -$292K ﹤0.01% 3833
2022
Q2
$449K Sell
22,125
-25,816
-54% -$524K ﹤0.01% 3410
2022
Q1
$1.19M Buy
47,941
+21,375
+80% +$529K ﹤0.01% 3086
2021
Q4
$923K Sell
26,566
-1,395
-5% -$48.5K ﹤0.01% 3506
2021
Q3
$758K Buy
27,961
+23,112
+477% +$627K ﹤0.01% 3446
2021
Q2
$126K Sell
4,849
-37,141
-88% -$965K ﹤0.01% 4672
2021
Q1
$905K Buy
41,990
+40,340
+2,445% +$869K ﹤0.01% 3456
2020
Q4
$36K Buy
1,650
+1,164
+240% +$25.4K ﹤0.01% 5471
2020
Q3
$7K Sell
486
-220
-31% -$3.17K ﹤0.01% 6211
2020
Q2
$16K Sell
706
-148
-17% -$3.35K ﹤0.01% 5834
2020
Q1
$12K Sell
854
-543
-39% -$7.63K ﹤0.01% 5896
2019
Q4
$23K Sell
1,397
-35,828
-96% -$590K ﹤0.01% 5723
2019
Q3
$1.3M Buy
37,225
+18,170
+95% +$636K ﹤0.01% 2987
2019
Q2
$1.08M Buy
19,055
+14,433
+312% +$815K ﹤0.01% 3009
2019
Q1
$338K Sell
4,622
-34,762
-88% -$2.54M ﹤0.01% 3583
2018
Q4
$2.51M Buy
39,384
+24,969
+173% +$1.59M ﹤0.01% 2257
2018
Q3
$1.44M Buy
14,415
+10,873
+307% +$1.08M ﹤0.01% 2854
2018
Q2
$252K Sell
3,542
-45,336
-93% -$3.23M ﹤0.01% 3954
2018
Q1
$5.09M Buy
48,878
+33,461
+217% +$3.48M ﹤0.01% 1839
2017
Q4
$1.55M Buy
15,417
+12,614
+450% +$1.27M ﹤0.01% 2708
2017
Q3
$98K Sell
2,803
-548
-16% -$19.2K ﹤0.01% 4453
2017
Q2
$80K Buy
3,351
+3,238
+2,865% +$77.3K ﹤0.01% 4421
2017
Q1
$3K Buy
+113
New +$3K ﹤0.01% 6224